Clinical trial
Selective Intra-Arterial Hypothermia Combined With Endovascular Treatment for Acute Basilar Artery Occlusion (CHILL- BAO): A Multicenter, Prospective, Open-Label, Blinded-Endpoint, Randomized Controlled Trial
NCT07896655 is registered in ClinicalTrials.gov with Guangdong Second Provincial General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Selective Intra-Arterial Hypothermia Combined With Endovascular Treatment for Acute Basilar Artery Occlusion (CHILL- BAO): A Multicenter, Prospective, Open-Label, Blinded-Endpoint, Randomized Controlled Trial
- Lead sponsor
- Guangdong Second Provincial General Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 31, 2026
- Completion date
- March 31, 2030
- Enrollment
- 818 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke, basilar artery occlusion
Arms
As registered; 2 arms.
-
Hypothermia group
Following successful reperfusion with endovascular treatment (EVT), participants in the hypothermia group will receive a selective intra-arterial infusion of 350 mL of 4°C normal saline at a fixed rate of 30 mL/min. No dose escalation will be performed.
-
Normothermia group
Receive a total of 350 ml of room temperature (22-25°C) saline infusion based on EVT treatment; the infusion rate is the same as that of the hypothermia group
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Distribution of Modified Rankin Scale Scores at 90 Days
The distribution of modified Rankin Scale (mRS) scores at 90 (±7) days after randomization will be assessed across all seven categories (0-6) using a shift analysis. Scores range from 0 (no symptoms) to 6 (death); lower scores indicate less disability.
Lead sponsor's other trials
Guangdong Second Provincial General Hospital, most recent start first.
+9 more trials See the organization page
Similar trials
Same condition (Ischemic Stroke) and phase, most recent start first.
+921 more trials See the condition page